Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed Haider

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Cell Metabolism|September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast CancerSimon R Lord, Wei-Chen Cheng, Dan Liu, et al.
Nature Communications|March 12, 2026
Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitorsCallum Walker, Gabriel Kollarovic, Daniel Weekes, et al.
Cancer Research|October 23, 2025
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast CancerAlicia M Chenoweth, Anthony Cheung, Jitesh Chauhan, et al.
Cancer Research|February 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular CarcinomaRenée L Flaherty, Flavia Hughes, George Sflomos, et al.
Nature Communications|February 14, 2025
Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasisOscar Maiques, Marta C Sallan, Roman Laddach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2023
Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC StudyHisham Mehanna, Davy Rapozo, Sandra V von Zeidler, et al.
Nature Genetics|July 31, 2023
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress responsePhilip Bland, Harry Saville, Patty T Wai, et al.
Cancer Research|January 29, 2021
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast CancerBarrie Peck, Philip Bland, Ioanna Mavrommati, et al.
Nature Communications|March 6, 2026
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapyWinnie Fernando, Jarama Clucas, Alberto Rizzo, et al.
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Cell Metabolism|September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast CancerSimon R Lord, Wei-Chen Cheng, Dan Liu, et al.
Nature Communications|March 12, 2026
Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitorsCallum Walker, Gabriel Kollarovic, Daniel Weekes, et al.
Cancer Research|October 23, 2025
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast CancerAlicia M Chenoweth, Anthony Cheung, Jitesh Chauhan, et al.
Cancer Research|February 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular CarcinomaRenée L Flaherty, Flavia Hughes, George Sflomos, et al.
Nature Communications|February 14, 2025
Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasisOscar Maiques, Marta C Sallan, Roman Laddach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2023
Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC StudyHisham Mehanna, Davy Rapozo, Sandra V von Zeidler, et al.
Nature Genetics|July 31, 2023
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress responsePhilip Bland, Harry Saville, Patty T Wai, et al.
Cancer Research|January 29, 2021
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast CancerBarrie Peck, Philip Bland, Ioanna Mavrommati, et al.
Nature Communications|March 6, 2026
Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapyWinnie Fernando, Jarama Clucas, Alberto Rizzo, et al.
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Pageof 21